How do I select patients for treatment with extended adjuvant therapies such as neratinib?

G. Thomas Budd, MD

G. Thomas Budd, MD, on advances in extended adjuvant HER2+ early breast cancer.


Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here